TABLE 3.
Critical events.
| Critical events | PRE (n = 120) | PANDEMIC (n = 384) | |||
|---|---|---|---|---|---|
| n (%) | Total, n | n (%) | Total, n | p‐value a | |
| All critical events | 67 (56) | 120 | 218 (57) | 384 | 0.86 |
| RDI <85% | 32 (27) | 120 | 115 (30) | 384 | 0.49 |
| Time to the first visit ≥3 months b | |||||
| Symptom | 27 (34) | 79 | 109 (40) | 275 | 0.37 |
| Screening | 3 (11) | 28 | 3 (4) | 81 | 0.16 |
| Postponement ≥15 days | 13 (11) | 120 | 46 (12) | 384 | 0.73 |
| Postponement ≥2 cycles | 33 (28) | 120 | 78 (20) | 384 | 0.10 |
| Start of Adj ≥91 days after surgery | 1 (2) | 55 | 12 (7) | 182 | 0.17 |
Abbreviations: Adj, adjuvant chemotherapy; RDI, relative dose intensity.
a
Chi‐square test.
b
Excluding patients who were diagnosed with breast cancer while under follow‐up for other cancers in our hospital.